Purpose:Runs of homozygosity (ROHs) represent a measure of the extent of autozygosity and are correlated with the extent of inbreeding. Recently, it has been suggested that ROHs may contribute to the risk of colorectal cancer (CRC). The high rate of consanguinity and CRC in the Saudi population prompted us to test the role of autozygosity in the CRC risk. Methods: We compared 48 Saudi CRC patients to 100 ethnically matched controls, processed on the Affymetrix 250K StyI SNP GeneChip platform and analyzed using the plink package. Results: We could find no evidence of a significant relationship between autozygosity and CRC risk. Conclusion: The negative results in our study add additional significance to what has been previously reported in literature, as this is the first study to address these questions in an inbred population. Our subgroup analysis of patients with microsatellite unstable-positive tumors as compared with other groups did not significantly change our results. Although these results do not rule out the presence of recessively acting CRC-predisposing genes in a small percentage of patients, which our relatively small sample size could not capture, they suggest that such genes are unlikely to account for the disturbingly high incidence of CRC in our consanguineous population.Genet Med advance online publication 5 April 2012.
Purpose:Runs of homozygosity (ROHs) represent a measure of the extent of autozygosity and are correlated with the extent of inbreeding. Recently, it has been suggested that ROHs may contribute to the risk of colorectal cancer (CRC). The high rate of consanguinity and CRC in the Saudi population prompted us to test the role of autozygosity in the CRC risk. Methods: We compared 48 Saudi CRC patients to 100 ethnically matched controls, processed on the Affymetrix 250K StyI SNP GeneChip platform and analyzed using the plink package. Results: We could find no evidence of a significant relationship between autozygosity and CRC risk. Conclusion: The negative results in our study add additional significance to what has been previously reported in literature, as this is the first study to address these questions in an inbred population. Our subgroup analysis of patients with microsatellite unstable-positive tumors as compared with other groups did not significantly change our results. Although these results do not rule out the presence of recessively acting CRC-predisposing genes in a small percentage of patients, which our relatively small sample size could not capture, they suggest that such genes are unlikely to account for the disturbingly high incidence of CRC in our consanguineous population.Genet Med advance online publication 5 April 2012.
Authors: Faisal F Alabbas; Ssakher M Al-Otaibi; Majed H Chamsi Pasha; Abdullah M Alghamdi; Hisham M Al-Hindi; Mahmoud S Al-Ahwal; Basem S El-Deek Journal: J Cancer Educ Date: 2016-06 Impact factor: 2.037
Authors: Fabienne Koenigstein; Felix Boekstegers; James F Wilson; Macarena Fuentes-Guajardo; Rolando Gonzalez-Jose; Gabriel Bedoya; Maria Cátira Bortolini; Victor Acuña-Alonzo; Carla Gallo; Andres Ruiz Linares; Francisco Rothhammer; Justo Lorenzo Bermejo Journal: Hum Mol Genet Date: 2022-03-21 Impact factor: 6.150
Authors: Francisco C Ceballos; Peter K Joshi; David W Clark; Michèle Ramsay; James F Wilson Journal: Nat Rev Genet Date: 2018-01-15 Impact factor: 53.242
Authors: Hisham Eldai; Sathish Periyasamy; Saeed Al Qarni; Maha Al Rodayyan; Sabeena Muhammed Mustafa; Ahmad Deeb; Ebthehal Al Sheikh; Mohammed Afzal; Mohammed Afzal Khan; Mishal Johani; Zeyad Yousef; Mohammad Azhar Aziz Journal: PLoS One Date: 2013-10-30 Impact factor: 3.240
Authors: Hauke Thomsen; Miguel Inacio da Silva Filho; Michael Fuchs; Sabine Ponader; Elke Pogge von Strandmann; Lewin Eisele; Stefan Herms; Per Hoffmann; Andreas Engert; Kari Hemminki; Asta Försti Journal: PLoS One Date: 2016-04-28 Impact factor: 3.240
Authors: Badri N Vardarajan; Daniel J Schaid; Christiane Reitz; Rafael Lantigua; Martin Medrano; Ivonne Z Jiménez-Velázquez; Joseph H Lee; Mahdi Ghani; Ekaterina Rogaeva; Peter St George-Hyslop; Richard P Mayeux Journal: Genet Med Date: 2014-11-13 Impact factor: 8.822